Biosimilar insulin is manufactured following the strictest safety protocols. Its efficacy is similar to that of reference. Protein molecules, such as insulin, are copied in such a way that both the biosimilar and the original contain the same protein.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
